SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,684 | -11.7% | 773,867 | +18.2% | 0.01% | -8.3% |
Q2 2023 | $3,041 | -4.2% | 654,468 | -4.8% | 0.01% | -14.3% |
Q1 2023 | $3,173 | -30.1% | 687,235 | +22.3% | 0.01% | -36.4% |
Q4 2022 | $4,538 | -99.9% | 561,828 | -11.1% | 0.02% | +15.8% |
Q3 2022 | $3,504,000 | +1.7% | 631,800 | -4.5% | 0.02% | +5.6% |
Q2 2022 | $3,447,000 | +76.2% | 661,615 | +177.8% | 0.02% | +125.0% |
Q1 2022 | $1,956,000 | -8.5% | 238,157 | +65.7% | 0.01% | 0.0% |
Q4 2021 | $2,137,000 | -37.9% | 143,718 | -21.2% | 0.01% | -38.5% |
Q3 2021 | $3,442,000 | -16.8% | 182,288 | -18.1% | 0.01% | -18.8% |
Q2 2021 | $4,135,000 | -23.5% | 222,469 | -6.3% | 0.02% | -23.8% |
Q1 2021 | $5,404,000 | +107.1% | 237,393 | +97.6% | 0.02% | +110.0% |
Q4 2020 | $2,609,000 | +104.6% | 120,163 | -5.3% | 0.01% | +100.0% |
Q3 2020 | $1,275,000 | +75.6% | 126,910 | +35.6% | 0.01% | +66.7% |
Q2 2020 | $726,000 | -20.0% | 93,566 | +5.2% | 0.00% | -40.0% |
Q1 2020 | $908,000 | +81.2% | 88,946 | +95.7% | 0.01% | +150.0% |
Q4 2019 | $501,000 | +79.6% | 45,447 | +48.0% | 0.00% | +100.0% |
Q3 2019 | $279,000 | +170.9% | 30,711 | +239.0% | 0.00% | – |
Q2 2019 | $103,000 | +1371.4% | 9,058 | +1365.7% | 0.00% | – |
Q1 2019 | $7,000 | – | 618 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |